Emerging therapeutic strategy for mitigating cancer progression through inhibition of sirtuin-1 and epithelial-mesenchymal transition.
Pathol Res Pract
; 251: 154907, 2023 Nov.
Article
em En
| MEDLINE
| ID: mdl-37925819
ABSTRACT
With 8.8 million deaths worldwide, cancer is the major reason for the high rate of fatalities. Malignancy's commencement, progression, development, metastasis, and therapy resistance have all been correlated with the epithelial-to-mesenchymal transition (EMT) pathway. EMT promotes the cancer cells' metastatic spread and starts the development of treatment resistance. Sirtuin-1 (SIRT1) is a histone deacetylase that is important for signaling, cell persistence, and apoptosis. It does this by deacetylating important cell signaling molecules and proteins that are associated with apoptosis. The function of SIRT1 in EMT and cancer progression, as well as the emerging therapeutic strategy of treating cancer through the inhibition of SIRT1 and EMT will be discussed in detail.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Sirtuína 1
/
Neoplasias
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article